20 Jun 2019 Avacta and Selexis partner to develop cell line for clinical manufacturing Investors | Therapeutics
12 Jun 2019 Avacta’s Chief Scientific Officer to Present at Major US Conference Investors | Therapeutics
03 Jun 2019 TMAC Programme Accelerates: Clinical Trial Planned for Early 2020 Investors | Therapeutics
10 Dec 2018 Avacta and LG Chem Life Sciences agree multi-target Affimer® therapeutics development alliance Investors | Therapeutics
12 Nov 2018 Avacta’s Chief Scientific Officer to Present Recent Data at Major European Conference Investors | Therapeutics